Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 26.76B | 24.67B | 21.55B | 24.59B | 21.52B | 20.71B |
Gross Profit | 5.65B | 4.65B | 3.91B | 5.00B | 3.92B | 3.71B |
EBITDA | 3.06B | 2.52B | 2.00B | 2.93B | 2.15B | 2.00B |
Net Income | 2.02B | 1.55B | 999.00M | 1.97B | 1.33B | 1.22B |
Balance Sheet | ||||||
Total Assets | 33.80B | 34.64B | 30.16B | 29.52B | 29.73B | 26.08B |
Cash, Cash Equivalents and Short-Term Investments | 8.20B | 8.36B | 7.63B | 5.57B | 6.44B | 4.75B |
Total Debt | 1.68B | 1.63B | 1.38B | 1.73B | 1.55B | 1.51B |
Total Liabilities | 15.45B | 17.19B | 14.73B | 14.83B | 16.46B | 14.32B |
Stockholders Equity | 18.35B | 17.45B | 15.42B | 14.69B | 13.27B | 11.76B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 774.00M | 2.81B | -363.00M | 1.94B | -1.90B |
Operating Cash Flow | 0.00 | 1.01B | 3.41B | -214.00M | 2.12B | -1.72B |
Investing Cash Flow | 0.00 | -234.00M | -589.00M | -150.00M | -186.00M | -177.00M |
Financing Cash Flow | 0.00 | -79.00M | -770.00M | -518.00M | -260.00M | -73.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥20.13B | 8.25 | 4.84% | 16.52% | 41.05% | ||
78 Outperform | ¥18.01B | 7.75 | 4.54% | 7.14% | 48.60% | ||
75 Outperform | ¥92.94B | 17.60 | 5.29% | 0.68% | -32.97% | ||
74 Outperform | ¥90.55B | 12.60 | 2.48% | 17.01% | 16.10% | ||
72 Outperform | ¥20.02B | 7.93 | 5.08% | -4.51% | -4.46% | ||
65 Neutral | $10.75B | 15.72 | 5.20% | 1.90% | 3.09% | -27.42% | |
64 Neutral | ¥21.81B | 24.17 | 6.21% | 3.00% | -62.93% |